Effect of country or continent of treatment on outcome after aneurysmal subarachnoid hemorrhage: Clinical article

Journal of Neurosurgery

Volumn 111, Issue 1, 2009, Pages 67-74

  Lipsman, Nir ^a   Tolentino, Jocelyn ^b   Macdonald, R Loch ^a  

^a ST MICHAEL'S HOSPITAL   (Canada)

^b UNIVERSITY OF CHICAGO MEDICAL CENTER   (United States)

Author keywords

Cerebral aneurysm; Country; Geography; Outcome; Subarachnoid hemorrhage

Indexed keywords

ADULT; AFRICA; AGED; ANEURYSM; ARTICLE; AUSTRALIA; BLOOD CLOTTING; CONTROLLED STUDY; CONVALESCENCE; DATA BASE; DEATH; DISABILITY; EUROPE; GEOGRAPHY; GLASGOW OUTCOME SCALE; HEALTH CENTER; HEMODILUTION; HUMAN; MAJOR CLINICAL STUDY; NORTH AMERICA; PERSISTENT VEGETATIVE STATE; PRIORITY JOURNAL; SUBARACHNOID HEMORRHAGE; TREATMENT OUTCOME;

ADOLESCENT; ADULT; AFRICA; AUSTRALIA; CHILD; CHILD, PRESCHOOL; COMBINED MODALITY THERAPY; EUROPE; HUMANS; INFANT; LOGISTIC MODELS; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEUROPROTECTIVE AGENTS; NORTH AMERICA; OCEANIA; PREGNATRIENES; PROGNOSIS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RISK FACTORS; SUBARACHNOID HEMORRHAGE;

EID: 67650810122     PISSN: 00223085     EISSN: 19330693     Source Type: Journal    
DOI: 10.3171/2008.10.JNS08184     Document Type: Article

References (31)

1. Bardach NS, Zhao S, Gress DR, Lawton MT, Johnston SC: Association between subarachnoid hemorrhage outcomes and number of cases treated at California hospitals. Stroke 33:1851-1856, 2002
2. Berman MF, Solomon RA, Mayer SA, Johnston SC, Yung PP: Impact of hospital-related factors on outcome after treatment of cerebral aneurysms. Stroke 34:2200-2207, 2003
3. Black N: Why we need observational studies to evaluate the effectiveness of health care. BMJ 312:1215-1218, 1996
4. Braunholtz DA, Edwards SJ, Lilford RJ: Are randomized clinical trials good for us (in the short term)? Evidence for a "trial effect." J Clin Epidemiol 54:217-224, 2001
5. Brott T, Adams HP Jr, Olinger CP, Marler JR, Barsan WG, Biller J, et al: Measurements of acute cerebral infarction: a clinical examination scale. Stroke 20:864-870, 1989 (Pubitemid 19188240)
6. Cross DT III, Tirschwell DL, Clark MA, Tuden D, Derdeyn CP, Moran CJ, et al: Mortality rates after subarachnoid hemorrhage: variations according to hospital case volume in 18 states. J Neurosurg 99:810-817, 2003 (Pubitemid 37314914)
7. de Rooij NK, Linn FH, van der Plas JA, Algra A, Rinkel GJ: Incidence of subarachnoid haemorrhage: a systematic review with emphasis on region, age, gender and time trends. J Neurol Neurosurg Psychiatry 78:1365-1372, 2007 (Pubitemid 350221419)
8. Drake CG, Hunt WE, Sano K, Kassell N, Teasdale G, Pertuiset B, et al: Report of World Federation of Neurological Surgeons committee on a universal subarachnoid hemorrhage grading scale. J Neurosurg 68:985-986, 1988
9. Elijovich L, Dreyer NA, VanDenBos J, Johnston SC: Undertreatment and outcomes of non-traumatic subarachnoid hemorrhage by hospital volume: a multi-state study. Stroke 39: 536, 2008 (Abstract)
10. Glick HA, Polsky D, Willke RJ, Alves WM, Kassell N, Schulman K: Comparison of the use of medical resources and outcomes in the treatment of aneurysmal subarachnoid hemorrhage between Canada and the United States. Stroke 29: 351-358, 1998 (Pubitemid 28086675)
11. Haley EC Jr, Kassell NF, Apperson-Hansen C, Maile MH, Alves WM: A randomized, double-blind, vehicle-controlled trial of tirilazad mesylate in patients with aneurysmal subarachnoid hemorrhage: a cooperative study in North America. J Neurosurg 86:467-474, 1997 (Pubitemid 27097093)
12. Jennett B, Bond M: Assessment of outcome after severe brain damage. A practical scale. Lancet 1:480-484, 1975
13. Johnston SC, Dowd CF, Higashida RT, Lawton MT, Duckwiler GR, Gress DR: Predictors of rehemorrhage after treatment of ruptured intracranial aneurysms: the Cerebral Aneurysm Rerupture After Treatment (CARAT) study. Stroke 39:120-125, 2008
14. Kassell NF, Haley ECJ, Apperson-Hansen C, Alves WM: Randomized, double-blind, vehicle-controlled trial of tirilazad mesylate in patients with aneurysmal subarachnoid hemorrhage: a cooperative study in Europe, Australia, and New Zealand. J Neurosurg 84:221-228, 1996 (Pubitemid 26039472)
15. Kassell NF, Torner JC, Haley EC Jr, Jane JA, Adams HP, Kongable GL: The international cooperative study on the timing of aneurysm surgery. Part 1: overall management results. J Neu rosurg 73:18-36, 1990 (Pubitemid 20206379)
16. Kassell NF, Torner JC, Jane JA, Haley EC Jr, Adams HP: The International Cooperative Study on the Timing of Aneurysm Surgery. Part 2: surgical results. J Neurosurg 73:37-47, 1990 (Pubitemid 20206380)
17. Lanzino G, Kassell NF: Double-blind, randomized, vehicle-controlled study of high-dose tirilazad mesylate in women with aneurysmal subarachnoid hemorrhage. Part II. A cooperative study in North America. J Neurosurg 90:1018-1024, 1999 (Pubitemid 29241167)
18. Lanzino G, Kassell NF, Dorsch NW, Pasqualin A, Brandt L, Schmiedek P, et al: Double-blind, randomized, vehicle-controlled study of high-dose tirilazad mesylate in women with aneurysmal subarachnoid hemorrhage. Part I. a cooperative study in Europe, Australia, New Zealand, and South Africa. J Neurosurg 90:1011-1017, 1999 (Pubitemid 29241166)
19. Lavados PM, Hennis AJ, Fernandes JG, Medina MT, Legetic B, Hoppe A, et al: Stroke epidemiology, prevention, and management strategies at a regional level: Latin America and the Caribbean. Lancet Neurol 6:362-372, 2007 (Pubitemid 46389614)
20. Molyneux AJ, Kerr RS, Yu LM, Clarke M, Sneade M, Yarnold JA, et al: International subarachnoid aneurysm trial (ISAT) of neurosurgical clipping versus endovascular coiling in 2143 patients with ruptured intracranial aneurysms: a randomised comparison of effects on survival, dependency, seizures, rebleeding, subgroups, and aneurysm occlusion. Lancet 366: 809-817, 2005 (Pubitemid 41557380)
21. Niskanen MM, Hernesniemi JA, Vapalahti MP, Kari A: One-year outcome in early aneurysm surgery: prediction of outcome. Acta Neurochir (Wien) 123:25-32, 1993 (Pubitemid 23240668)
22. Ohman J, Heiskanen O: Timing of operation for ruptured supratentorial aneurysms: a prospective randomized study. J Neurosurg 70:55-60, 1989
23. Rosengart AJ, Schultheiss KE, Tolentino J, Macdonald RL: Prognostic factors for outcome in patients with aneurysmal subarachnoid hemorrhage. Stroke 38:2315-2321, 2007 (Pubitemid 47457575)
24. Rothwell PM, Coull AJ, Giles MF, Howard SC, Silver LE, Bull LM, et al: Change in stroke incidence, mortality, case-fatality, severity, and risk factors in Oxfordshire, UK from 1981 to 2004 (Oxford Vascular Study). Lancet 363:1925-1933, 2004
25. Shea AM, Reed SD, Curtis LH, Alexander MJ, Villani JJ, Schulman KA: Characteristics of nontraumatic subarachnoid hemorrhage in the United States in 2003. Neurosurgery 61: 1131-1137, 2007
26. Suarez JI: Outcome in neurocritical care: advances in monitoring and treatment and effect of a specialized neurocritical care team. Crit Care Med 34:S232-S238, 2006
27. Teasdale G, Jennett B: Assessment of impaired consciousness and coma: a practical scale. Lancet 2:81-84, 1974
28. Torner JC, Kassell NF, Wallace RB, Adams HPJ: Preoperative prognostic factors for rebleeding and survival in aneurysm patients receiving antifibrinolytic therapy: report of the cooperative aneurysm study. Neurosurgery 9:506-513, 1981 (Pubitemid 12239556)
29. Varelas PN, Schultz L, Conti M, Spanaki M, Genarrelli T, Hacein-Bey L: The impact of a neuro-intensivist on patients with stroke admitted to a neurosciences intensive care unit. Neurocrit Care 9:293-299, 2008
30. Vermeij FH, Hasan D, Bijvoet HW, Avezaat CJ: Impact of medical treatment on the outcome of patients after aneurysmal subarachnoid hemorrhage. Stroke 29:924-930, 1998 (Pubitemid 28228150)
31. Vibo R, Korv J, Roose M: The Third Stroke Registry in Tartu, Estonia: decline of stroke incidence and 28-day case-fatality rate since 1991. Stroke 36:2544-2548, 2005